Chris Karlovich
Frederick National Laboratory for Cancer Research(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Radiomics and Machine Learning in Medical Imaging, Molecular Biology Techniques and Applications
Most-Cited Works
- → Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer(2015)660 cited
- → Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients(2016)655 cited
- → TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository(2021)501 cited
- → Heterogeneity Underlies the Emergence of EGFR T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor(2015)460 cited
- → A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma(2016)284 cited
- → The Son of sevenless Gene Product: a Putative Activator of Ras(1992)276 cited
- → Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma(2017)272 cited
- → Correction: Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients(2016)245 cited
- → Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study(2019)218 cited
- → Exosome-Based Detection of EGFR T790M in Plasma from Non–Small Cell Lung Cancer Patients(2018)211 cited